ROHTO PHARMACEUTICAL CO.,LTD. 4527Short Interest

No institution currently reports a short position of 0.5% or more in ROHTO PHARMACEUTICAL CO.,LTD. (4527). The last disclosure was on 2026-11-16 (Morgan Stanley MUFG Securities Co., Ltd., 0.46%).

Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
13 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (7.32% in total). It also excludes 4 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2022-10-21
Latest disclosure2026-11-16 (Morgan Stanley MUFG Securities Co., Ltd., 0.46%)
Reporting institutions5 firms (13 reports)
Peak estimated short interest7.87% (2025-09-16, 2 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • BNP Paribas Financial Markets SNC
  • Barclays Bank PLC
  • Morgan Stanley MUFG Securities Co., Ltd.
  • Integrated Core Strategies (Asia) Pte. Ltd.
  • MERRILL LYNCH INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2025-08-12 BNP Paribas Financial Markets SNC Position 173 shares Ratio 7.32% ▲7.09% −1,149,500 No report for 1+ year
2026-11-16 Morgan Stanley MUFG Securities Co., Ltd. Position 1,099,586 shares Ratio 0.46% ▼0.06% −140,109 Below 0.5%
2025-10-01 Barclays Bank PLC Position 887,638 shares Ratio 0.37% ▼0.18% −429,936 Below 0.5%
2025-01-06 MERRILL LYNCH INTERNATIONAL Position 308,760 shares Ratio 0.13% ▼0.37% −893,259 Below 0.5%
2022-10-28 Integrated Core Strategies (Asia) Pte. Ltd. Position 92,760 shares Ratio 0.07% ▼0.43% −506,479 Below 0.5%

Disclosure History 13 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-11-16 Morgan Stanley MUFG Securities Co., Ltd. Position 1,099,586 shares Ratio 0.46% ▼0.06% −140,109 Below 0.5%
2026-11-09 Morgan Stanley MUFG Securities Co., Ltd. Position 1,239,695 shares Ratio 0.52% ▲0.04% +85,144 —
2026-10-26 Morgan Stanley MUFG Securities Co., Ltd. Position 1,154,551 shares Ratio 0.48% ▼0.02% −45,567 Below 0.5%
2026-10-19 Morgan Stanley MUFG Securities Co., Ltd. Position 1,200,118 shares Ratio 0.50% ▲0.06% —
2025-10-01 Barclays Bank PLC Position 887,638 shares Ratio 0.37% ▼0.18% −429,936 Below 0.5%
2025-09-16 Barclays Bank PLC Position 1,317,574 shares Ratio 0.55% ▲0.17% —
2025-08-12 BNP Paribas Financial Markets SNC Position 173 shares Ratio 7.32% ▲7.09% −1,149,500 —
2025-08-05 BNP Paribas Financial Markets SNC Position 1,149,673 shares Ratio 0.48% ▼0.03% −62,400 Below 0.5%
2025-08-01 BNP Paribas Financial Markets SNC Position 1,212,073 shares Ratio 0.51% ▲0.11% —
2025-01-06 MERRILL LYNCH INTERNATIONAL Position 308,760 shares Ratio 0.13% ▼0.37% −893,259 Below 0.5%
2024-12-30 MERRILL LYNCH INTERNATIONAL Position 1,202,019 shares Ratio 0.50% ▲0.50% —
2022-10-28 Integrated Core Strategies (Asia) Pte. Ltd. Position 92,760 shares Ratio 0.07% ▼0.43% −506,479 Below 0.5%
2022-10-21 Integrated Core Strategies (Asia) Pte. Ltd. Position 599,239 shares Ratio 0.50% ▲0.09% —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
WAKAMOTO PHARMACEUTICAL CO.,LTD.4512 Standard Market(Domestic) Pharmaceutical Pharmaceutical
Nippon Shinyaku Co.,Ltd.4516 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
CHUGAI PHARMACEUTICAL CO.,LTD.4519 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Large70
KAKEN PHARMACEUTICAL CO.,LTD.4521 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Eisai Co.,Ltd.4523 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ONO PHARMACEUTICAL CO.,LTD.4528 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
SANTEN PHARMACEUTICAL CO.,LTD.4536 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Fuso Pharmaceutical Industries,Ltd.4538 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
NIPPON CHEMIPHAR CO.,LTD.4539 Standard Market(Domestic) Pharmaceutical Pharmaceutical
TSUMURA & CO.4540 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400